Porntep Siriwanarangsun1, Attapon Cheepsattayakorn1,2* and Ruangrong Cheepsattayakorn3
1Faculty of Medicine, Western University, Pathumtani Province, Thailand
210th Zonal Tuberculosis and Chest Disease Center, Chiang Mai, Thailand
3Department of Pathology, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand
*Corresponding Author: Attapon Cheepsattayakorn, 10th Zonal Tuberculosis and Chest Disease Center, Chiang Mai, Thailand.
Received: November 28, 2020; Published: December 22, 2020
In the mid-1960s, coronavirus were found that it can infect both humans and animals (birds and mammals), whereas novel coronavirus-2019 (2019-nCoV or COVID-19) with closed relation to SARS-CoV was first identified from a patient with pneumonia, related to the cluster of acute respiratory illness cases from Wuhan, China. Presently, there is no best vaccine to end the COVID-19 pandemic.
Citation: Attapon Cheepsattayakorn., et al. “Transforming A Coronavirus Protein into A Nanoparticle for Production of Promising COVID-19 Vaccine". Acta Scientific Microbiology 4.2 (2021): 01.
Copyright: © 2021 Attapon Cheepsattayakorn., et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Open Access by
Acta Scientific is licensed under a Creative Commons Attribution 4.0 International License
Based on a work at https://actascientific.com
ff
